AccuGene

AccuGene is a South Korean biotechnology company specializing in the development of high-purity, long single-stranded DNA (ssDNA) synthesis technology for CRISPR-mediated gene editing. The company's proprietary platform addresses a critical bottleneck in the gene therapy industry by providing high-quality DNA templates that enhance Homology-Directed Repair (HDR) efficiency while minimizing cellular toxicity. AccuGene's products are designed to facilitate precise gene knock-ins, making them essential tools for the development of next-generation cell and gene therapies. Beyond its core synthesis capabilities, the company is expanding its reach into molecular diagnostics and research services for global pharmaceutical partners. AccuGene is positioned as a key infrastructure provider in the rapidly growing genome engineering market.